Statistics for Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study

Total visits

views
Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study 0

Total visits per month

views
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 0
December 2025 0

File Visits

views
Salman et al. - 2020 - Real-life data on the effectiveness and safety of .pdf 11